Leading Inflammatory Bowel Disease Event Invites Audience to Be Part of This Year's Agenda
New York, NY (PRWEB) August 26, 2013 -- The Crohn’s & Colitis Foundation of America (CCFA) and Imedex would like to announce the September 3 abstract submission deadline for 2013 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference.
Held beach-side in Hollywood, Florida on December 12-14, 2013, one of the goals of the conference is to present the best new scientific research in IBD and advance knowledge on the state of the science. Health care professionals with an interest in the treatment of pediatric and adult patients with inflammatory bowel diseases are invited to share their research initiatives with the healthcare community by submitting an abstract.
According to conference co-chair Dr. Stephen B. Hanauer, "Presenting an abstract or poster at this conference is a great opportunity and provides excellent exposure and visibility. Accepted abstracts will be published in the journal Inflammatory Bowel Diseases and scheduled for oral or poster presentation."
Abstracts are subject to acceptance by the Scientific Committee. Abstracts should be submitted at http://www.advancesinibd.com by September 3, 2013. Accepted abstracts will be presented at the conference on December 12-14, 2013 in Hollywood, Florida.
Additionally, a limited number of travel grants will be offered to GI fellows-in-training, nurse practitioners and nurses to attend this conference. These scholarship awards are available to assist with conference-related travel expenses by providing 1) free conference registration and 2) a scholarship of $500. Details can be found at http://www.advancesinibd.com/.
Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference is the premier conference for healthcare professionals and researchers who study and manage patients with inflammatory bowel diseases. Co-chaired by Richard P. MacDermott, MD, MACG and Stephen B. Hanauer, MD, FACG, the outstanding faculty is comprised of over 60 expert specialists who will lead the sessions and interact with conference attendees. Endorsed by the ACG, AGA, and NASPGHAN, this three-day conference offers exciting workshops and a two-track format designed for clinicians, researchers, allied health professionals, nurses, and pediatric gastroenterologists. All tracks will be comprised of the foremost bench to bedside leaders from across the country.
About the Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation of America (CCFA) is the largest voluntary non-profit health organization dedicated to finding cures for Inflammatory Bowel Diseases (IBD). CCFA’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research, providing educational resources for patients and their families, medical professionals, and the public, and furnishing supportive services for those afflicted with IBD. For more information, visit http://www.ccfa.org, call 888-694-8872, like us on Facebook, or follow us on Twitter.
About Imedex®
Imedex is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.
Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, education is the best medicine.®
Carlton Sanderson, 770-751-7332, [email protected]
Share this article